A method to measure time-varying viscoelastic properties using nanoscale vibration in intact cardiac myocytes

一种利用完整心肌细胞的纳米级振动测量时变粘弹性特性的方法

基本信息

项目摘要

1.To test whether the minute vibration technique can separate viscosity and elasticity of the cardiac myocyte, we quantitatively assessed the regional myocardial elasticity and viscosity using this technique. Time-varying regional myocardial viscosity as well as elastance increased from diastole to systole and linearly correlated with time-varying ventricular elastance.2.We applied this technique in the regional myocardium to an isolated cardiac myocyte. Nanoscale vibration was generated by atomic force microscope. However, there was only a small difference in the calculated viscoelasticity between the end-systolic and the diastolic phases. Moreover, there was no change of this difference between systole and diastole under the unstressed conditions after the contractility was enhanced by dobutamine.3.We developed a new device to stretch an isolated cardiac myocyte and tried to measure the viscoelasticity of a cardiac myocyte under the loading conditions. However, the isolated cardiac m … More yocytes were easily peeled off from the culture sheet because it was difficult to stretch the sheet uniformly.4.Maximizing yield of viable cardiac myocytes is most important in the processing of small human myocardial biopsies. We established the conditions of protease and collagenase digestion of ventricular myocardium to obtain viable cardiac myocytes in adults rats. The combination of 4U/ml protease (type XXIV) and 400U/ml collagenase-A was more effective than either enzyme alone in increasing viable cardiac myocytes.5.We developed a computer model to relate cardiomyocyte-level viscoelasticity to whole-heart contractility. This model was based on Laplace's law and applied across a multilayer of myocardium. We could integrate the stress-strain relationship in cell-level to the pressure-volume relationship in heart-level.In the next phase, we are planning to measure the viscoelasticity of an isolated cardiac myocyte by the cell fixation technique that uses a pair of carbon fibers to clamp a cardiac myocyte. Less
1.为验证微振动技术能否分离心肌细胞的粘度和弹性,本研究应用微振动技术定量测定了局部心肌的弹性和粘度。时变局部心肌粘度和弹性从舒张期到收缩期逐渐增加,并与时变心室弹性呈线性相关。2.我们将此技术应用于离体心肌细胞的局部心肌。利用原子力显微镜产生纳米级振动。然而,在收缩末期和舒张期之间的计算粘弹性只有很小的差异。在无应力状态下,多巴酚丁胺增强心肌细胞的收缩力后,收缩期与舒张期的这种差异没有改变。3.我们研制了一种新的心肌细胞拉伸装置,并尝试测量了心肌细胞在负荷状态下的粘弹性。然而,孤立的心脏M ...更多信息 由于难以均匀地拉伸培养片,因此很容易从培养片上剥离出心肌细胞。4.在处理小型人心肌活组织检查中,最大限度地提高活心肌细胞的产量是最重要的。我们建立了成年大鼠心室肌蛋白酶和胶原酶消化的条件,以获得存活的心肌细胞。4U/ml蛋白酶(XXIV型)和400 U/ml胶原酶-A的组合比单独使用任何一种酶在增加存活心肌细胞方面更有效。5.我们开发了一个计算机模型,将心肌细胞水平的粘弹性与整个心脏的收缩力联系起来。该模型基于拉普拉斯定律并应用于多层心肌。我们可以将细胞水平的应力-应变关系整合到心脏水平的压力-容积关系中。在下一阶段,我们计划通过使用一对碳纤维夹持心肌细胞的细胞固定技术来测量分离的心肌细胞的粘弹性。少

项目成果

期刊论文数量(21)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Effects of Ca2+ channel antagonists on nerve stimulation-induced and ischemia-induced myocardial interstitial acetylcholine release in cats
Ca2+通道拮抗剂对猫神经​​刺激和缺血诱导的心肌间质乙酰胆碱释放的影响
Automated drug delivery system to control systemic arterial pressure, cardiac output, and left heart filling pressure in acute decompensated heart failure.
自动给药系统可控制急性失代偿性心力衰竭的全身动脉压、心输出量和左心充盈压。
  • DOI:
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    0
  • 作者:
    T.Ito et al.;M.Kawashita.et al.;Y.Jujimura;Kazuhiro NAKASHIMA et al.;Uemura K et al.
  • 通讯作者:
    Uemura K et al.
Dynamic characteristics of carotid sinus pressure-nerve activity transduction in rabbits.
家兔颈动脉窦压力-神经活动传导的动态特征。
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kawada T et al.
  • 通讯作者:
    Kawada T et al.
Myocardial interstitial choline and glutamate levels during acute myocardial ischaemia and local ouabain administration
  • DOI:
    10.1111/j.1365-201x.2005.01444.x
  • 发表时间:
    2005-07-01
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kawada, T;Yamazaki, T;Sugimachi, M
  • 通讯作者:
    Sugimachi, M
Sympathetic neural regulation of heart rate is robust against high plasma catecholamines.
  • DOI:
    10.2170/physiolsci.rp006006
  • 发表时间:
    2006-06
  • 期刊:
  • 影响因子:
    0
  • 作者:
    T. Kawada;T. Miyamoto;Yuichiro Miyoshi;S. Yamaguchi;Y. Tanabe;A. Kamiya;T. Shishido;M. Sugimachi
  • 通讯作者:
    T. Kawada;T. Miyamoto;Yuichiro Miyoshi;S. Yamaguchi;Y. Tanabe;A. Kamiya;T. Shishido;M. Sugimachi
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SHISHIDO Toshiaki其他文献

SHISHIDO Toshiaki的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SHISHIDO Toshiaki', 18)}}的其他基金

Development of a new method to estimate the ventricular viscosity using an integrated macro-micro model
开发一种使用集成宏观微观模型估计心室粘度的新方法
  • 批准号:
    16K15451
  • 财政年份:
    2016
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Development of optimized hemodynamic therapy guided by mean circulatory filling pressure or stressed blood volume.
开发以平均循环充盈压或应激血容量为指导的优化血液动力学治疗。
  • 批准号:
    22591758
  • 财政年份:
    2010
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似国自然基金

基于NLRP3/IL-1β信号探讨α7nAChR介导巨噬细胞—心肌细胞互作在Aβ诱导房颤心房重构中的作用及机制研究
  • 批准号:
    82300356
  • 批准年份:
    2023
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
肌特异性miR-499在心肌细胞增殖和凋亡中作用的研究
  • 批准号:
    81070112
  • 批准年份:
    2010
  • 资助金额:
    10.0 万元
  • 项目类别:
    面上项目

相似海外基金

Smart drug evaluation system for matured engineered cardiomyocyte tissue
成熟工程化心肌细胞组织智能药物评价系统
  • 批准号:
    23H01382
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Virtual drug screen reveals context-dependent inhibition of cardiomyocyte hypertrophy
虚拟药物筛选揭示了心肌细胞肥大的情境依赖性抑制
  • 批准号:
    10678351
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
A role for cardiomyocyte pannexin 1 in non-ischemic heart failure
心肌细胞pannexin 1在非缺血性心力衰竭中的作用
  • 批准号:
    10680109
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Modulators of cardiomyocyte structure to promote functional recovery during cardiac regeneration and repair
心肌细胞结构调节剂促进心脏再生和修复过程中的功能恢复
  • 批准号:
    10751640
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Immune Response-Mediated Regulation of Cardiomyocyte Growth and Renewal
免疫反应介导的心肌细胞生长和更新调节
  • 批准号:
    10625948
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Label-free single-cell imaging for quality control of cardiomyocyte biomanufacturing
用于心肌细胞生物制造质量控制的无标记单细胞成像
  • 批准号:
    10675976
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Supply and Demand: Oxygen and Workload Regulate Cardiomyocyte Proliferation
供需:氧气和工作量调节心肌细胞增殖
  • 批准号:
    10572541
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Regulation of cardiomyocyte proliferation by the Reptin ATPase
Reptin ATP酶对心肌细胞增殖的调节
  • 批准号:
    10747229
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Mechanisms of cardiomyocyte dysfunction in pediatric septic shock
小儿感染性休克心肌细胞功能障碍的机制
  • 批准号:
    10580624
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Ethnically Diverse iPSC-Cardiomyocyte Panel for Pharmacogenomics and Drug Safety Testing
用于药物基因组学和药物安全性测试的种族多样化 iPSC-心肌细胞小组
  • 批准号:
    10755624
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了